“Avantium is a big story in the bioeconomy, but the relationships with big companies as investors are not easy”. To say it at the Sustainable & Circular Bioeconomy Conference in Brussels on October 22 was Jos Peeters, managing partner, founder and director of Capricorn Venture. Indeed, Avantium and BASF are in a dispute about the future of their Synvina joint venture. The companies disagree on the timing for the fulfilment of the criteria to invest in the commercial-scale plant for FDCA (furandicarboxylic acid).
The chemical giant BASF and bse Engineering have signed an exclusive joint development agreement for BASF to provide custom made catalysts for a new chemical energy storage process. This process will enable economically viable transformation of excess current and off-gas carbon dioxide (CO2) into the chemical energy storage methanol in small-scale, delocalized production units.
“Biotech is becoming increasingly important to the mainstream chemical industry as the demand for more sustainable solutions intensifies. Biotech is especially well-suited to help with some of the industry’s biggest challenges”. To say it – in this exclusive interview with Il Bioeconomista – is Christophe Schilling, founder and CEO of Genomatica, a widely-recognized bioengineering leader for the chemical industry. The San Diego-based biotechnology company develops and licenses bio-based manufacturing processes for the production of intermediate and basic chemicals.
Since being named CEO in May 2009, Christophe Schilling has led Genomatica to widespread recognition as a leader in industrial biotechnology, with a commercialized first process, top-tier licensees, strong investors and an unrivaled string of awards for engineering (Kirkpatrick), science (EPA Presidential Green Chemistry), industry leadership (voted #1 Hottest three years in a row by Biofuels Digest), and company culture (The Scientist as a Best Place to Work). Schilling frequently speaks on industry trends at major conferences and serves as a member of the World Economic Forum Global Agenda Council on Biotechnology.
Interview by Mario Bonaccorso
BASF and the Dutch leading chemical technology company Avantium yesterday announced that they have established a joint venture (JV) called Synvina for the production and marketing of furandicarboxylic acid (FDCA) produced from renewable resources (fructose from plants as feedstock rather than conventional oil derivatives), as well as marketing of polyethylenefuranoate (PEF), based on this new chemical building block.
German chemical colossus Basf and The Linde Group, one of the leading gases and engineering companies in the world, successfully completed a joint pilot project to improve capture of carbon dioxide (CO2) from flue gas at a coal fired power plant at the National Carbon Capture Center (NCCC). The NCCC is a U.S. Department of Energy (DOE) research facility managed and operated by Southern Company, in Wilsonville, Alabama. Since January 2015, the project operated a pilot plant under a cooperative agreement with DOE’s National Energy Technology Laboratory (NETL). Based on the successful completion, Basf and Linde will begin larger-scale testing and explore commercial opportunities.
The German chemical giant BASF and the Dutch leading chemical technology company Avantium today announced that they have signed a letter of intent and entered into exclusive negotiations to establish a joint venture (JV) for the production and marketing of furandicarboxylic acid (FDCA) produced from renewable resources, as well as marketing of polyethylenefuranoate (PEF), based on this new chemical building block.
BASF and Genomatica have expanded the scope of their license agreement for the production of 1,4-butanediol based on renewable feedstock (renewable BDO) using Genomatica’s patented process. The parties added certain countries in Southeast Asia to their initial agreement, which focused on North America.
“The bio-based PolyTHF 1000 is identical in quality to the petrochemical-based product.” To say it is Andrej Brejc, director Renewable Diols from BASF’s Intermediates division (sales to third parties of about 2.8 billion euro in 2014), which has made bio-based Polytetrahydrofuran 1000 (PolyTHF® 1000) available for the first time. The chemical company headquartered in Ludwigshafen is now providing this intermediate to selected partners for testing various applications in a large scale.
Chemical giant Basf has decided to exit the current R&D collaboration with Novozymes and Cargill to develop a bio-based process for producing 3-hydroxypropionic (3-HP) and acrylic acid from renewable raw materials.
BASF, Cargill and Novozymes announced the achievement of another milestone in their joint development of technologies to produce acrylic acid from renewable raw materials. The team has demonstrated the successful conversion of 3-hydroxypropionic acid (3-HP) to glacial acrylic acid and superabsorbent polymers. Moreover they have selected the process for further scale-up.